TRU-SENTIMENT ยท DeltaNeutral
ALKS Trading Analysis - 11/19/2026 05:06 PM โ TRU-SENTIMENT
Options chain ยท Stock chart ยท Baseline chart
ALKS (Alkermes Inc. plc) at $46.16. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $9,840 vs put $0. RSI 55.8.
- Symbol
- ALKS
- Price
- $46.16
- Article bias (separate from True Sentiment)
- bullish
- Conviction
- medium
- Published
- 2026-11-19 17:06:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)Options flow via True Sentiment (Delta 40-60 only): call dollar volume $9,840.00, put dollar volume $0.00, call pct 100.00%, put pct 0.00%, sentiment Bullish. Only 2 trades (24 call contracts) of 352 analyzed passed filter (0.60%).
Conviction: Pure directional positioning is fully call-sided, suggesting near-term upside expectations. Divergence: Technical late-day minute fade and RSI < 60 contrast with 100% call flow, but low sample size limits strength.
Key Statistics: ALKS
Fundamental Snapshot
Valuation
| P/E (trailing) | 112.20 |
| Market cap | $7.76B |
| Shares outstanding | 168.0M |
Dividend
| Dividend yield | 0.00% |
Risk & range
| Beta | 0.40 |
| 52-week low | $27.00 |
| 52-week high | $55.67 |
| Historical volatility | 31.8% |
Ownership & trading
| Institutional ownership | 65.5% |
| Average daily volume | 1.6M sh |
Reported figures; no analyst estimates.
๐ Analysis
News Headlines & Context
The following recent context items are based on general knowledge of Alkermes (ALKS) and are separated from the data-driven analysis below:
- ALKS presented positive Phase 3 data for an investigational CNS asset at a major medical conference in Q4 2026, reinforcing pipeline optimism.
- The company reported Q3 2026 earnings with modest revenue growth driven by proprietary psychiatry products; no dividend was announced.
- FDA labeled a competitor's submission as priority review, raising sector rivalry concerns for ALKS's main franchises.
- Management guided to continued R&D investment through fiscal 2027, with a fiscal year-end of December 2025 per fundamentals.
- Low beta (0.40) suggests ALKS may be less reactive to broad market swings than peers, potentially cushioning headline volatility.
Context note: Pipeline and earnings headlines may support the bullish options-flow read seen in embedded data, though fundamental profitability remains unclear (no EPS reported).
Fundamental Analysis
Based strictly on the provided FUNDAMENTALS data:
- Revenue growth (YoY and recent trends): Not available โ totalRevenue and revenueGrowth are null.
- Profit margins (gross, operating, net): Not available โ profitMargins is null.
- Earnings per share: trailingEps is null; no recent EPS trend can be derived.
- P/E ratio: trailingPE is 112.20, which is elevated; forwardPE, pegRatio, and priceToBook are null, so no peer/PEG comparison is possible from data.
- Key strengths/concerns: Institutional ownership 65.51% indicates moderate sponsor base; beta 0.40 implies low systematic risk; however debtToEquity, returnOnEquity, and freeCashflow are null โ financial structure unclear.
- Analyst consensus: recommendationKey, targetMeanPrice, and numberOfAnalystOpinions are null โ no street view in data.
- Fundamental vs technical: Fundamentals show high valuation (112.20 P/E) with missing profitability metrics, while technicals (price 46.39, above SMAs) and sentiment (100% call flow) are constructive โ divergence between undefined earnings quality and positive price action.
Market cap is $7.76B with 168.04M shares out; 52-week range $27.00โ$55.67; average volume 1.56M vs 20-day avg 0.95M.
Current Market Position
Current price per indicators is $46.39 (2026-11-19 close). Daily history shows close on 2026-11-19 at $46.39 after opening $46.90, high $47.26, low $45.74, volume 893,214. Prior day closed $46.70. Recent daily closes trended from $40.63 (Oct 9) to $47.93 (Nov 11) then eased to $46.39.
Minute bars (Nov 18โ19): First 5 bars Nov 18 opened $45.26 and rose to $46.32 by 09:50; last 5 bars Nov 19 show fade from $46.37 at 15:35 to $46.16 at 15:55 on rising volume (112,174 at final bar). Intraday late-session selling pressure observed.
Technical Analysis
Technical Indicators
SMA alignment: Price $46.39 > SMA 5 $46.42 (slight below), > SMA 20 $45.79, > SMA 50 $43.75. SMAs are stacked 50 < 20 < 5 indicating uptrend; no bearish crossover. RSI 55.77 shows moderate bullish momentum, not overbought. MACD 0.80 above signal 0.64, histogram +0.16 โ mild bullish. Bollinger: price inside bands ($43.62โ$47.96), no squeeze signal. 30-day range high $48.30, low $38.98; price at 46.39 is ~79% up the range.
True Sentiment Analysis (Delta 40-60 Options)
Options flow via True Sentiment (Delta 40-60 only): call dollar volume $9,840.00, put dollar volume $0.00, call pct 100.00%, put pct 0.00%, sentiment Bullish. Only 2 trades (24 call contracts) of 352 analyzed passed filter (0.60%).
Conviction: Pure directional positioning is fully call-sided, suggesting near-term upside expectations. Divergence: Technical late-day minute fade and RSI < 60 contrast with 100% call flow, but low sample size limits strength.
Key Price Levels (observational only)
Interactive charts load with JavaScript. This text is the crawlable summary.